Author

Derek A Wainwright

Loyola University Chicago Stritch School of Medicine - Cited by 5,773 - Neuro-oncology - Aging - Immunology - Immunotherapy

Biography

Assistant Professor of Neurological Surgery, Medicine (Hematology and Oncology) and Microbiology-Immunology.BS: Bradley University (2002) MS: Loyola University Chicago (2004) PhD: Loyola University Chicago (2009)Postdoctoral Scholar: University of Chicago, Surgery (2011) Postdoctoral Fellow: University of Chicago, Surgery (2013)
Title
Cited by
Year
NK cell-based cancer immunotherapy: from basic biology to clinical development
S Liu, V Galat, Y Galat4, YKA Lee, D Wainwright, J WuJournal of hematology & oncology 14, 1-17, 2021202
269
2021
Immunosuppressive IDO in cancer: mechanisms of action, animal models, and targeting strategies
L Zhai, A Bell, E Ladomersky, KL Lauing, L Bollu, JA Sosman, B Zhang, ...Frontiers in immunology, 1185, 2020202
113
2020
Targeting CD73 to augment cancer immunotherapy
M Roh, DA Wainwright, JD Wu, Y Wan, B ZhangCurrent opinion in pharmacology 53, 66-, 2020202
76
2020
Advanced age increases immunosuppression in the brain and decreases immunotherapeutic efficacy in subjects with glioblastoma
E Ladomersky, L Zhai, KL Lauing, A Bell, J Xu, M Kocherginsky, B Zhang, ...Clinical Cancer Research 26 (19), 5232-5245, 2020202
54
2020
Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno …
P Chuntova, F Chow, PB Watchmaker, M Galvez, AB Heimberger, ...Neuro-oncology 23 (3), 356-375, 2021202
48
2021
Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma
L Zhai, A Bell, E Ladomersky, KL Lauing, L Bollu, B Nguyen, M Genet, ...Clinical cancer research 27 (23), 6514-6528, 2021202
37
2021
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug
J Bi, A Khan, J Tang, AM Armando, S Wu, W Zhang, RC Gimple, A Reed, ...Cell reports 37 (5), 2021202
31
2021
The impact of beta blockers on survival outcomes in patients with non–small-cell lung cancer treated with immune checkpoint inhibitors
MS Oh, A Guzner, DA Wainwright, NA Mohindra, YK Chae, A Behdad, ...Clinical lung cancer 22 (1), e57-e62, 2021202
29
2021
Glioblastoma as an age-related neurological disorder in adults
M Kim, E Ladomersky, A Mozny, M Kocherginsky, K O’Shea, ZZ Reinstein, ...Neuro-oncology advances 3 (1), vdab125, 2021202
27
2021
A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors
S Otto-Meyer, R DeFaccio, C Dussold, E Ladomersky, L Zhai, KL Lauing, ...Brain, Behavior, & Immunity-Health 2, 1000, 2020202
25
2020
Tryptophan metabolism in brain tumors—IDO and beyond
M Platten, M Friedrich, DA Wainwright, V Panitz, CA OpitzCurrent opinion in immunology 70, 57-66, 2021202
23
2021
Circadian regulator CLOCK drives immunosuppression in glioblastoma
W Xuan, WH Hsu, F Khan, M Dunterman, L Pang, DA Wainwright, ...Cancer Immunology Research 10 (6), 770-784, 2022202
19
2022
Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy
F Basher, P Dhar, X Wang, DA Wainwright, B Zhang, J Sosman, Z Ji, ...Journal of hematology & oncology 13, 1-16, 2020202
17
2020
Systematic review of the kynurenine pathway and psychoneurological symptoms among adult cancer survivors
H Li, T Liu, LW Heinsberg, MB Lockwood, DA Wainwright, MK Jang, ...Biological research for nursing 22 (4), 472-484, 2020202
10
2020
Mid-life epigenetic age, neuroimaging brain age, and cognitive function: coronary artery risk development in young adults (CARDIA) study
Y Zheng, M Habes, M Gonzales, R Pomponio, I Nasrallah, S Khan, ...Aging (Albany NY) 14 (4), 1691, 2022202
8
2022
Identification and characterization of a novel indoleamine 2, 3-Dioxygenase 1 protein degrader for glioblastoma
LR Bollu, PV Bommi, PJ Monsen, L Zhai, KL Lauing, A Bell, M Kim, ...Journal of Medicinal Chemistry 5 (23), 1542-152, 2022202
6
2022
Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation
P Dhar, F Basher, Z Ji, L Huang, S Qin, DA Wainwright, J Robinson, ...Communications Biology 4 (1), 90, 2021202
5
2021
CD11c+ CD163+ cells and signal transducer and activator of transcription 3 (STAT3) expression are common in melanoma leptomeningeal disease
H Najem, A Marisetty, C Horbinski, J Long, JT Huse, IC Glitza Oliva, ...Frontiers in immunology 12, 75893, 2021202
4
2021
Next steps for immunotherapy in glioblastoma
TQ Cao, DA Wainwright, C Lee-Chang, J Miska, AM Sonabend, ...Cancers 1 (16), 023, 2022202
4
2022
Amelioration of graft-versus-host disease by exopolysaccharide from a commensal bacterium
O Kalinina, S Talley, J Zamora-Pineda, W Paik, EM Campbell, KL KnightThe Journal of Immunology 206 (9), 2101-2108, 2021202
3
2021

Referred From: https://scholar.google.com/citations?user=ZgHEwgcAAAAJ&hl=en

Cited by
Citations 5773
h-index 36
i10-index 70
Recommended Journals
Open Access Journals